Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Bedlack

Showing results (11-20 of 77) with videos related to

Pageof 8
Sort By:
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|March 3, 2010
Roaring in the ears: patulous Eustachian tube in bulbar amyotrophic lateral sclerosisKerri Schellenberg, Richard Bedlack, Debara Tucci
Expert Review of Neurotherapeutics|January 27, 2023
An evaluation of the combination of sodium phenylbutyrate and taurursodiol for the treatment of amyotrophic lateral sclerosisYuyao Sun, Xiaoyan Li, Richard Bedlack
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases|December 24, 2002
Limitations of inferences from observational databases in amyotrophic lateral sclerosis: all that glitters is not goldCarmel Armon, Roberto J Guiloff, Richard Bedlack
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 17, 2020
Total serum immunoglobulin A in ALSJesse Crayle, Mai Elmallah, John Sleasman, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 13, 2025
Examining IGFBP7 as a potential therapeutic target in people with ALSAndrew Brown, Colin Stubberfield, Fernando Vieira, et al.
The American Journal of Hospice & Palliative Care|December 17, 2020
Continuing Non-Invasive Ventilation During Amyotrophic Lateral Sclerosis-Related Hospice Care Is Medically, Administratively, and Financially FeasiblePhilip J Choi, Michael Murn, Roberta Turner, et al.
BMJ Open|November 14, 2019
Study protocol for a randomised, double-blind, placebo-controlled study evaluating the Efficacy of cannabis-based Medicine Extract in slowing the disease pRogression of Amyotrophic Lateral sclerosis or motor neurone Disease: the EMERALD trialBerzenn Urbi, Simon Broadley, Richard Bedlack, et al.
Neurology|February 20, 2025
A Retrospective Analysis of ALS Clusters Near Algae Blooms in North Carolina (P5-11.019)Alexandra Linares, Xiaoyan Li, Lisa Satterwhite, et al.
Journal of Clinical Neuromuscular Disease|May 23, 2023
Clenbuterol Treatment Is Safe and Associated With Slowed Disease Progression in a Small Open-Label Trial in Patients With Amyotrophic Lateral SclerosisXiaoyan Li, Dwight D Koeberl, Michael W Lutz, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 28, 2020
ALS clinical research learning institutes (ALS-CRLI): empowering people with ALS to be research ambassadorsRichard Bedlack, Allison Pogemiller, Jeremy Shefner, et al.
Pageof 8

Showing results (11-20 of 77) with videos related to

Sort By:
Pageof 8
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|March 3, 2010
Roaring in the ears: patulous Eustachian tube in bulbar amyotrophic lateral sclerosisKerri Schellenberg, Richard Bedlack, Debara Tucci
Expert Review of Neurotherapeutics|January 27, 2023
An evaluation of the combination of sodium phenylbutyrate and taurursodiol for the treatment of amyotrophic lateral sclerosisYuyao Sun, Xiaoyan Li, Richard Bedlack
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases|December 24, 2002
Limitations of inferences from observational databases in amyotrophic lateral sclerosis: all that glitters is not goldCarmel Armon, Roberto J Guiloff, Richard Bedlack
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 17, 2020
Total serum immunoglobulin A in ALSJesse Crayle, Mai Elmallah, John Sleasman, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 13, 2025
Examining IGFBP7 as a potential therapeutic target in people with ALSAndrew Brown, Colin Stubberfield, Fernando Vieira, et al.
The American Journal of Hospice & Palliative Care|December 17, 2020
Continuing Non-Invasive Ventilation During Amyotrophic Lateral Sclerosis-Related Hospice Care Is Medically, Administratively, and Financially FeasiblePhilip J Choi, Michael Murn, Roberta Turner, et al.
BMJ Open|November 14, 2019
Study protocol for a randomised, double-blind, placebo-controlled study evaluating the Efficacy of cannabis-based Medicine Extract in slowing the disease pRogression of Amyotrophic Lateral sclerosis or motor neurone Disease: the EMERALD trialBerzenn Urbi, Simon Broadley, Richard Bedlack, et al.
Neurology|February 20, 2025
A Retrospective Analysis of ALS Clusters Near Algae Blooms in North Carolina (P5-11.019)Alexandra Linares, Xiaoyan Li, Lisa Satterwhite, et al.
Journal of Clinical Neuromuscular Disease|May 23, 2023
Clenbuterol Treatment Is Safe and Associated With Slowed Disease Progression in a Small Open-Label Trial in Patients With Amyotrophic Lateral SclerosisXiaoyan Li, Dwight D Koeberl, Michael W Lutz, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 28, 2020
ALS clinical research learning institutes (ALS-CRLI): empowering people with ALS to be research ambassadorsRichard Bedlack, Allison Pogemiller, Jeremy Shefner, et al.
Pageof 8